Hematology

Diagnosis & Lab Reports: Decoding the Coombs Test

At a Glance

The Coombs test, or Direct Antiglobulin Test (DAT), is the primary lab test used to diagnose autoimmune hemolytic anemia (AIHA). Doctors combine this test with markers of cell destruction, such as low haptoglobin and high LDH, to confirm if your immune system is destroying red blood cells.

Deciphering your laboratory reports can feel like learning a new language. However, these numbers are the map your care team uses to track how quickly your red blood cells are being destroyed and how hard your body is working to replace them. By understanding the key markers of hemolysis (red blood cell destruction) and the Coombs test, you can more effectively partner with your hematologist.

The Markers of Destruction: Is it Hemolysis?

When red blood cells (RBCs) burst, they spill their contents into your bloodstream and use up certain protective proteins. Your doctor looks for these five signs to confirm active hemolysis:

Hemoglobin (Low): This measures your blood’s oxygen-carrying capacity. A low level defines your anemia and its severity ^[1].
Reticulocyte Count (High): Reticulocytes are “baby” red blood cells. A high count shows your bone marrow is working overtime to pump out new cells to replace the ones being destroyed ^[2]^[3].
Lactate Dehydrogenase or LDH (High): This enzyme lives inside RBCs. When they burst, LDH spills into the blood, causing your levels to spike ^[4]^[5].
Haptoglobin (Low or Absent): Think of haptoglobin as a “cleanup crew.” It binds to the debris from broken cells to clear it away. In active AIHA, the cleanup crew gets used up faster than it can be replaced ^[4]^[5].
Indirect Bilirubin (High): When RBCs break down, they release a yellow pigment. High levels cause jaundice (yellowing of the skin and eyes) ^[4]^[6].

The Direct Antiglobulin Test (DAT) / Coombs Test

The DAT is the definitive test used to see if your immune system is the culprit. It searches for antibodies or “complement” proteins stuck to the surface of your red blood cells ^[3]^[7].

Decoding Your DAT Result

A complete report should be “monospecific,” meaning it specifies exactly what was found on your cells:

IgG Positive: Usually suggests Warm AIHA. Your body has coated the cells with IgG antibodies ^[7]^[8].
C3d (Complement) Positive: Suggests Cold Agglutinin Disease (CAD). This means your immune system has “tagged” the cells with a protein called complement ^[7]^[9].
Both IgG and C3d Positive: Often indicates Mixed AIHA ^[10].

Important Pitfalls to Watch For

DAT-Negative AIHA: About 5–10% of people with clear hemolysis have a “negative” DAT ^[11]. This can happen if the number of antibodies is too low for standard tests to see, or if the antibodies are “low-affinity” and fall off during testing ^[12]^[13]. If you have hemolysis but a negative DAT, your doctor should use “enhanced” techniques like LISS (Low-Ionic Strength Saline) or column agglutination ^[14]^[15].
False Positives: A positive DAT does not always mean you have AIHA. Some healthy people or people with other conditions can have a positive DAT without any actual cell destruction ^[5]^[8]. The diagnosis requires both a positive test and evidence of hemolysis.

Completeness Checklist

Review your lab report. To ensure a thorough workup, you should ideally see these components:

[ ] Complete Blood Count (CBC): To check Hemoglobin and Hematocrit.
[ ] Hemolysis Panel: LDH, Haptoglobin, and Bilirubin.
[ ] Reticulocyte Count: To see if your marrow is responding.
[ ] Monospecific DAT: Clearly stating if IgG, C3d, or both were found.
[ ] Blood Smear: A manual look at your cells under a microscope to check for “spherocytes” (tiny, round cells common in AIHA).
[ ] Screening for Underlying Causes: Tests for Lupus, CLL, or recent infections to see if the AIHA is “secondary” ^[16]^[17].

Previous: The Types of AIHA | Return to Overview | Next: Treatment Pathways

Common questions in this guide

What does a positive Coombs test or DAT mean?

A positive Direct Antiglobulin Test, also known as a Coombs test, means your immune system has placed antibodies or complement proteins on the surface of your red blood cells. Your doctor will look at the specific type of protein found, like IgG or C3d, to determine your exact AIHA subtype.

Can I have AIHA with a negative Coombs test?

Yes, about 5 to 10 percent of people with clear red blood cell destruction have a negative Coombs test. This can happen if the number of antibodies is too low for standard tests to detect. If you have signs of hemolysis, your doctor can order enhanced tests to look closer.

What are the main blood test markers for hemolysis?

Doctors look for a combination of five key markers to confirm active red blood cell destruction. These include low hemoglobin, low haptoglobin, a high reticulocyte count, high lactate dehydrogenase (LDH), and high indirect bilirubin.

What does it mean if my reticulocyte count is high?

Reticulocytes are young, newly made red blood cells. A high reticulocyte count indicates that your bone marrow is working overtime to pump out new cells to replace the mature red blood cells being destroyed by your immune system.

Curated prompts to bring to your next appointment.

1.What are my specific markers of hemolysis (Hemoglobin, Reticulocytes, LDH, Haptoglobin, and Bilirubin) today?
2.Was a 'monospecific' DAT performed to distinguish between IgG and C3d? What does that tell us about my subtype?
3.If my DAT was negative, have we ruled out 'DAT-negative AIHA' using more sensitive tests like LISS or column agglutination?
4.Is my reticulocyte count appropriately high? If not, what does that mean for my bone marrow's ability to keep up?
5.Does my lab report show any signs of 'agglutination' or 'clumping' that would suggest cold agglutinin disease?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References (17)

1
Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia.
Barcellini W, Fattizzo B
Disease markers 2015; (2015()):635670 doi:10.1155/2015/635670.
PMID: 26819490
2
Warm Autoimmune Hemolytic Anemia.
Brodsky RA
The New England journal of medicine 2019; (381(7)):647-654 doi:10.1056/NEJMcp1900554.
PMID: 31412178
3
Difficult Cases of Autoimmune Hemolytic Anemia: A Challenge for the Internal Medicine Specialist.
Fattizzo B, Giannotta JA, Serpenti F, Barcellini W
Journal of clinical medicine 2020; (9(12)) doi:10.3390/jcm9123858.
PMID: 33261016
4
[Hemolytic anemia].
Tuchscherer A, Chemnitz J
Der Internist 2015; (56(9)):1000-8 doi:10.1007/s00108-015-3661-8.
PMID: 26245867
5
Clinical and laboratory profile of patients with positive direct antiglobulin test attended at a university hospital in Goias, Brazil.
Mendes IC, de Assis PCGF, de Almeida RS, et al.
Hematology, transfusion and cell therapy 2024; (46 Suppl 5()):S65-S71 doi:10.1016/j.htct.2024.04.118.
PMID: 39095314
6
Laboratory Predictors of Hemolytic Anemia in Patients With Systemic Loxoscelism.
Jacobs JW, Bastarache L, Thompson MA
American journal of clinical pathology 2022; (157(4)):566-572 doi:10.1093/ajcp/aqab169.
PMID: 34643670
7
Patient ABO blood type is a major predictor of a positive DAT following a transfusion reaction.
Schnieders E, Leon J, Chapman JM, Knudson CM
Transfusion 2022; (62(9)):1715-1719 doi:10.1111/trf.17019.
PMID: 35836408
8
Critical evaluation of donor direct antiglobulin test positivity: Implications in cross-matching and lessons learnt.
Puri V, Chhikara A, Sharma G, et al.
Asian journal of transfusion science 2019; (13(1)):70-72 doi:10.4103/ajts.AJTS_125_17.
PMID: 31360017
9
The Direct Antiglobulin Test: Indications, Interpretation, and Pitfalls.
Parker V, Tormey CA
Archives of pathology & laboratory medicine 2017; (141(2)):305-310 doi:10.5858/arpa.2015-0444-RS.
PMID: 28134589
10
Efficacy of eculizumab in refractory life-threatening warm autoimmune hemolytic anemia associated with chronic myelomonocytic leukemia.
Gauchy AC, Hentzien M, Wynckel A, et al.
Clinical case reports 2020; (8(12)):2641-2644 doi:10.1002/ccr3.3250.
PMID: 33363796
11
A Rare Case of Successfully Treated Coombs Negative Immune Haemolytic Anaemia in Pregnancy.
Saha PK, Kaur J, Bagga R, et al.
Journal of clinical and diagnostic research : JCDR 2017; (11(2)):QD06-QD07 doi:10.7860/JCDR/2017/22274.9409.
PMID: 28384940
12
Diagnostic algorithm for classification and characterization of direct antiglobulin test-negative autoimmune hemolytic anemia with 1-year clinical follow-up.
Kamesaki T
Transfusion 2022; (62(1)):205-216 doi:10.1111/trf.16709.
PMID: 34668206
13
Diagnostic challenges in DAT-negative autoimmune haemolytic anaemia.
McDuff L, Lombard M, Calogero T, et al.
BMJ case reports 2025; (18(3)) doi:10.1136/bcr-2024-264551.
PMID: 40154553
14
Direct antibody test negative autoimmune hemolytic anemia with pulmonary tuberculosis: A diagnostic challenge.
Sheetal A, Ruby S, Dhirendra PS, et al.
Asian journal of transfusion science 2022; (16(2)):280-282 doi:10.4103/ajts.AJTS_75_20.
PMID: 36687553
15
[Progress in diagnosis and treatment of autoimmune hemolytic anemia].
Kamesaki T
[Rinsho ketsueki] The Japanese journal of clinical hematology 2019; (60(9)):1100-1107 doi:10.11406/rinketsu.60.1100.
PMID: 31597833
16
Understanding therapeutic emergencies in acute hemolysis.
Boutboul D, Touzot F, Szalat R
Intensive care medicine 2018; (44(4)):482-485 doi:10.1007/s00134-017-4918-6.
PMID: 28871399
17
Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review.
Autore F, Pasquale R, Innocenti I, et al.
Cancers 2021; (13(22)) doi:10.3390/cancers13225804.
PMID: 34830959

This page explains AIHA laboratory terminology and the Coombs test for educational purposes. Your hematologist is the best source for interpreting your specific blood work and diagnostic test results.

Get notified when new evidence is published on Autoimmune hemolytic anemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents